Suvorexant is associated with a low incidence of delirium in critically ill patients: a retrospective cohort study.

Tomoyuki MasuyamaMasamitsu SanuiNaoto YoshidaYusuke IizukaKunio OgiSatoko YagihashiKanae NagatomoYusuke SasabuchiAlan K Lefor

Published in: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society (2018)

Suvorexant was associated with decreased odds of transitioning to delirium in critically ill patients. The use of suvorexant may lower the incidence of delirium in ICU patients. Future prospective studies are warranted.

Keyphrases

cardiac surgery
end stage renal disease
risk factors
hip fracture
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
patient reported outcomes
case control